This article first appeared on GuruFocus.

Agilon Health Inc (NYSE:AGL) is set to release its Q3 2025 earnings on Nov 4, 2025. The consensus estimate for Q3 2025 revenue is $1.42 billion, and the earnings are expected to come in at -$0.16 per share. The full year 2025's revenue is expected to be $5.82 billion and the earnings are expected to be -$0.63 per share. More detailed estimate data can be found on the Forecast page.

Warning! GuruFocus has detected 4 Warning Signs with AGL.

Is AGL fairly valued? Test your thesis with our free DCF calculator.

Revenue estimates for Agilon Health Inc (NYSE:AGL) have declined from $5.96 billion to $5.82 billion for the full year 2025 and declined from $6.56 billion to $6.15 billion for 2026 over the past 90 days. Earnings estimates have decreased from -$0.36 per share to -$0.63 per share for the full year 2025 and from -$0.27 per share to -$0.38 per share for 2026 over the past 90 days.

In the previous quarter of 2025-06-30, Agilon Health Inc's (NYSE:AGL) actual revenue was $1.39 billion, which missed analysts' revenue expectations of $1.47 billion by -5.18%. Agilon Health Inc's (NYSE:AGL) actual earnings were -$0.25 per share, which missed analysts' earnings expectations of -$0.12 per share by -111.86%. After releasing the results, Agilon Health Inc (NYSE:AGL) was down by -51.51% in one day.

Based on the one-year price targets offered by 12 analysts, the average target price for Agilon Health Inc (NYSE:AGL) is $1.40 with a high estimate of $3.00 and a low estimate of $1.00. The average target implies an upside of 75.77% from the current price of $0.80.

Based on GuruFocus estimates, the estimated GF Value for Agilon Health Inc (NYSE:AGL) in one year is $9.90, suggesting an upside of 1142.94% from the current price of $0.80.

Based on the consensus recommendation from 18 brokerage firms, Agilon Health Inc's (NYSE:AGL) average brokerage recommendation is currently 3.0, indicating a \\"Hold\\" status. The rating scale ranges from 1 to 5, where 1 signifies strong buy, and 5 denotes sell.